Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12


ABOUT SUDOSCAN
Small nerve damage can be reversible if detected early!
The non-invasive medical device SUDOSCAN is a highly sensitive and reproducible tool for the early detection of peripheral neuropathy. Early detecting and follow-up of peripheral neuropathy could help monitor disease progression and assess treatment efficacy to improve patient management and control complications caused by diseases like diabetes.
“For us to improve nerve function and the quality of life of the individual, we had to do extensive measures: skin biopsy to look at nerve regeneration, nerve conduction studies to show enhancements of nerve conductions and quantitative sensory tests which have a wide variance. These tests are time consuming, laborious and full of error. Now, we have SUDOSCAN that can measure electrical conductance along with sweat gland function in only 2 minutes with instant results that are 75% sensitive, 98% specific and with less than 5% error*.”
*Schwarz PE, Brunswick P, Calvet JH. EZSCAN a new tool to detect diabetes risk. Br J Diabetes Vasc Dis 11:204-209.
*Schwarz PE, Brunswick P, Calvet JH. EZSCAN a new tool to detect diabetes risk. Br J Diabetes Vasc Dis 11:204-209.

SUDOSCAN BENEFITS
FAST
No patient preparation
Results in 3 minutes
Easy-to-read critical data points to help physicians reach a diagnosis
SECURE
Non-invasive
No fasting
Easy to operate
CE and FDA approvals
ACCURATE
Reproducible quantitative results
Independent from environmental conditions
Backed by evidence-based research
150 peer-reviewed journals publications
WHY SUDOSCAN IS CHOSEN BY PHYSICIANS ?
Learn why Physicians use SUDOSCAN during the diagnostic evaluation of Small Fiber and Autonomic Neuropathy for the early detection of potentially treatable diseases. Discover why your patients will appreciate a non-invasive test to monitor their disease and treatment outcome.
SUDOSCAN featured on the Discovery Channel Show – Innovations Series

Impeto Medical on Worldwide Business with Kathy Ireland

LATEST NEWS
Events
Successful Webinar “Management of autonomic dysfunction” – July 2021
July 16, 2021
No Comments
Read More →